The Centers for Medicare & Medicaid Services (CMS) and America’s Health Insurance Plans (AHIP), as part of a broad Core Quality Measures Collaborative of healthcare system participants, released seven sets of clinical quality measures. These measures support multi-payer alignment, for the first time, on core measures primarily for physician quality programs. This work is informing CMS’s implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) through its measure development plan and required rulemaking.

Increasingly patients and providers are interested in using remote monitoring devices to help with their healthcare. Researchers at the University of California Los Angeles (UCLA) sought to determine if these devices could be useful in preventing 180-day all-cause hospital readmissions for heart failure patients.

Biotronik announced a partnership with Maquet Medical Systems USA to distribute Biotronik peripheral vascular devices in the United States.

St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of the first-to-market MultiPoint Pacing technology featured on the Quadra line of cardiac resynchronization therapy defibrillators (CRT-D) and pacemakers.

February 17, 2016 — Up to 10 percent of people with high blood pressure have resistant hypertension — high blood pressure that remains elevated despite treatment with at least three blood pressure medications.

viosworks, cardiac MRI
Philips, ScanWise, MR conditional

For decades now, magnetic resonance imaging (MRI) has been noted for its excellent soft tissue imaging capability with zero radiation dose. It has been called the imaging modality of the future over and over, but due to its complexity, long exam times and high cost, its growth has been severely limited. This especially has been the case for cardiac MRI, which only accounts for about 1 percent of all MRI exams in the United States. However, new technologies introduced at the 2015 Radiological Society of North America (RSNA) meeting in December may encourage future expansion. 

Apervita Inc. announced the American College of Cardiology (ACC) will add a recognized tool for predicting atherosclerotic cardiovascular disease (ASCVD) to the growing body of analytics being distributed through the Apervita Marketplace.

By genetically reprogramming the most common type of cell in mammalian connective tissue, researchers at the University of Wisconsin-Madison have generated master heart cells — primitive progenitors that form the developing heart.

Heart Rhythm Society (HRS) Scientific Sessions

Heart Rhythm Society's 37th Annual Scientific Sessions, to be held in San Francisco, Calif., May 4-7, 2016 will have something for everyone — from networking opportunities to the latest science, education, and technology — focusing on the ideas, people, and technology that continue to propel our field forward.

Location:
Moscone Center
747 Howard Street
San Francisco, CA 94103

Mitral Valve, cardiovascular ultrasound, GE E95, cardiac ultrasound, comparison of ultrasound systems
Fujifilm, sonosite, iViz, POC ultrasound
cardiovascular ultrasound, GE E95
anatomical imaging, philips Epiq
lumify, app based ultrasound, Philips point of care ultrasound

(Read a 2018 update on cardiac ultrasound technologies "Recent Advances in Echocardiography Technology")

There were some big innovation trends in cardiac ultrasound in 2015. These included the launch of the first premium all touchscreen ultrasound system; the introduction of artificial intelligence to speed, simplify and make cardiac echo more reproducible; and a big advancement in image quality, approaching that of computed tomography (CT) scans.   
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now